Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-21-014969

Options or other derivatives

  • Director acquired 2,121 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ferrante Karen Jean Director 2021-04-01 Grant or award · Stock Option (Right to Buy) +2,121 $5.66 $12,000 2,121 D
Loading xslF345X03/doc4.xml…